| Autor: |
Taylor, Sarah A., Metch, Barbara, Balcerzak, Stanley P., Hanson, Karl H. |
| Zdroj: |
Investigational New Drugs; November 1990, Vol. 8 Issue: 4 p381-383, 3p |
| Abstrakt: |
Thirty-four patients with advanced soft tissue sarcomas were entered in a phase II trial of echinomycin. Patients received 1.2 mg/m2 intravenously (i.v.) weekly times four followed by a two week rest period. There were no objective responses. Dose limiting toxicity was gastrointestinal. Echinomycin given on this weekly schedule is inactive in treating previously treated patients with advanced soft tissue sarcomas. |
| Databáze: |
Supplemental Index |
| Externí odkaz: |
|
Full text from SpringerLink